Yan Ming-Tso, Yang Sung-Sen, Tseng Min-Hua, Cheng Chih-Jen, Tsai Jeng-Daw, Sung Chih-Chien, Hsu Yu-Juei, Lin Shih-Hua
Division of Nephrology, Department of Medicine, Cathay General Hospital, School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan.
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.
NPJ Genom Med. 2021 Aug 13;6(1):68. doi: 10.1038/s41525-021-00230-8.
Recurrent mutations in the SLC12A3 gene responsible for autosomal recessive Gitelman syndrome (GS) are frequently reported, but the exact prevalence is unknown. The rapid detection of recurrent SLC12A3 mutations may help in the early diagnosis of GS. This study was aimed to investigate the prevalence of recurrent SLC12A3 mutations in a Taiwan cohort of GS families and develop a simple and rapid method to detect recurrent SLC12A3 mutations. One hundred and thirty independent Taiwan families with genetically confirmed GS were consecutively enrolled to define recurrent SLC12A3 mutations and determine their prevalence. Using TaqMan probe-based real-time polymerase chain reaction, we designed a mutation detection plate with all recurrent mutations. We validated this mutation detection plate and tested its feasibility in newly diagnosed GS patients. A total of 57 mutations in the SLC12A3 gene were identified and 22 including 2 deep intronic mutations were recurrent mutations consisting of 87.1% (242/278, 18 triple) of all allelic mutations. The recurrent mutation-based TaqMan assays were fully validated with excellent sensitivity and specificity in genetically diagnosed GS patients and healthy subjects. In clinical validation, recurrent mutations were recognized in 92.0% of allelic mutations from 12 GS patients within 4 h and all were confirmed by direct sequencing. Recurrent SLC12A3 mutations are very common in Taiwan GS patients and can be rapidly identified by this recurrent mutation-based SLC12A3 mutation plate.
导致常染色体隐性吉特曼综合征(GS)的SLC12A3基因反复突变屡有报道,但其确切患病率尚不清楚。快速检测SLC12A3反复突变可能有助于GS的早期诊断。本研究旨在调查台湾GS家系队列中SLC12A3反复突变的患病率,并开发一种简单快速的方法来检测SLC12A3反复突变。连续招募了130个经基因确诊的台湾GS独立家系,以确定SLC12A3反复突变并确定其患病率。我们使用基于TaqMan探针的实时聚合酶链反应,设计了一个包含所有反复突变的突变检测板。我们对该突变检测板进行了验证,并在新诊断的GS患者中测试了其可行性。在SLC12A3基因中共鉴定出57个突变,其中22个(包括2个内含子深处的突变)为反复突变,占所有等位基因突变的87.1%(242/278,18个三联体)。基于反复突变的TaqMan检测法在基因确诊的GS患者和健康受试者中得到了充分验证,具有出色的敏感性和特异性。在临床验证中,4小时内从12名GS患者的等位基因突变中识别出92.0%的反复突变,且所有结果均经直接测序确认。SLC12A3反复突变在台湾GS患者中非常常见,通过这种基于反复突变的SLC12A3突变检测板可以快速识别。